TipRanks
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
US Market
BOLT
Bolt Biotherapeutics
RESEARCH TOOLSreports
Want to see BOLT full AI Analyst Report?

Bolt Biotherapeutics (BOLT) Income Statement

250 Followers

Bolt Biotherapeutics Income Statement

Last quarter (Q2 2026), Bolt Biotherapeutics's total revenue was $5.00K, a decrease of -99.72% from the same quarter last year. In Q2, Bolt Biotherapeutics's net income was $-7.72M. See Bolt Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.70M$ 7.69M$ 7.88M$ 5.73M$ 1.26M
Gross Profit
$ 6.20M$ 7.69M$ -53.67M$ -67.39M$ -74.39M
Operating Expenses
$ 40.84M$ 80.74M$ 22.53M$ 22.93M$ 18.39M
Depreciation and Amortization
$ 1.49M$ 1.78M$ 1.85M$ 1.67M$ 1.19M
EBITDA
$ -31.89M$ -66.45M$ -67.34M$ -86.43M$ -97.40M
Operating Income
$ -34.63M$ -73.05M$ -76.20M$ -90.32M$ -92.79M
Other Income/Expenses
$ 1.26M$ 9.93M$ 7.00M$ 2.22M$ -5.80M
Pretax Income
$ -33.38M$ -63.12M$ -69.20M$ -88.10M$ -98.59M
Net Income
$ -33.38M$ -63.12M$ -69.20M$ -88.10M$ -98.59M
Per Share Metrics
Basic EPS
$ -17.85$ -1.65$ -1.83$ -2.30$ -2.79
Diluted EPS
$ -17.85$ -1.65$ -1.83$ -2.30$ -2.79
Weighted Average Shares Outstanding
 1.87M 1.91M 1.89M 1.87M 1.87M
Weighted Average Shares Outstanding (Diluted)
 1.87M 1.91M 1.89M 1.87M 1.87M
Currency in USD

Bolt Biotherapeutics Earnings and Revenue History